Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 64.00
Bid: 63.00
Ask: 65.00
Change: 0.50 (0.79%)
Spread: 2.00 (3.175%)
Open: 63.50
High: 64.00
Low: 63.50
Prev. Close: 63.50
MYX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

11 Dec 2015 07:00

RNS Number : 7138I
MyCelx Technologies Corporation
11 December 2015
 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)("MYCELX" or the "Company")

Trading Update

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for commercial industrial markets worldwide, announces a trading update on its 2015 revenue and financial performance.

 

MYCELX has continued with its cost reduction measures and consequently, in line with the Company's previous guidance, the Company confirms that it will be at least cash neutral from operations in H2 2015. Net cash at year is expected to be not less than $3.7 million.

The Company now expects to report full year revenue for FY2015 that will be in line with that for FY2014, and will be in the region of $13.5 - 13.8 million (FY2014: $13.581 million). In response to continued weakening of the oil price during H2 2015, MYCELX's customers have increased focus on their own cost management and reduced their purchases of MYCELX media impacting the Company's ability to sustain its forecasted run rate.

The reduction in revenue is expected to result in a post-tax loss in the region of $3.4 - 3.8 million. The substantial reduction in the net loss of approximately 40% compared to FY2014 ($5.920m) is due to the cost reductions implemented by the Company in response to the current market conditions and which have been continuously monitored during H2 2015.

The Company will provide guidance on its revenue expectation for FY2016 in due course.

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, Interim CFO

 

 

Tel: +1 888 306 6843

RFC Ambrian Limited

Corporate Finance

Samantha Harrison

Jonathan Stephens

 

Corporate Broking

Jonathan Williams

Kim Eckhof

 

Tel: +44 20 3440 6800

Numis Securities Limited

Corporate Broking

James Black

Ben Stoop

 

Tel: +44 20 7260 1000

Bell Pottinger

Nick Lambert

Henry Lerwill

 

Tel: +44 20 3772 2500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKKDNPBDDFBD
Date   Source Headline
5th Nov 20217:00 amRNSDirector/PDMR Shareholding
28th Oct 20214:34 pmRNSHolding(s) in Company
14th Oct 20217:00 amRNSMiddle East Contract Win
29th Sep 20217:00 amRNSHalf Year Results Statement
31st Aug 20217:00 amRNSNotice of Interim Results & Investor Presentation
11th Aug 20217:00 amRNSHolding(s) in Company
4th Aug 20217:00 amRNSContract Award and Contract Extension
7th Jul 20215:41 pmRNSResult of AGM
4th Jun 20218:00 amRNSMailing of Annual Financial Report and AM Notice
26th May 20217:00 amRNSFinal Results for the year ending 31 December 2020
19th May 20217:00 amRNSInvestor Presentation
14th May 20217:00 amRNSPFAS System Validation
13th Apr 20211:49 pmRNSGrant of Options
23rd Mar 20217:00 amRNSBoard Changes
17th Mar 20213:37 pmRNSHolding(s) in Company
17th Mar 20212:35 pmRNSHolding(s) in Company
15th Mar 20217:00 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSTrading Update
18th Feb 20217:00 amRNSSale of MYCELX property in Duluth, USA
17th Feb 20214:32 pmRNSHolding(s) in Company
5th Jan 20212:32 pmRNSHolding(s) in Company
4th Jan 20217:00 amRNSHolding(s) in Company
27th Oct 20202:55 pmRNSResult of Annual Meeting
2nd Oct 20202:56 pmRNSNotice of Annual Meeting
22nd Sep 20207:00 amRNSHalf Year Results Statement
4th Sep 20207:00 amRNSAppointment of Nominated Adviser and Sole Broker
7th Aug 202011:50 amRNSDirector/PDMR Shareholding
22nd Jun 20207:00 amRNSContract extension with SABIC
19th Jun 20207:00 amRNSAnnual Financial Report
27th May 20207:00 amRNSFinal Results for the year ending 31 December 2019
11th May 20207:00 amRNSNew Project Award
14th Apr 20207:00 amRNSTrading Update
9th Mar 20207:00 amRNSClosure of Restricted Stock Line
5th Mar 20207:00 amRNSTrading Update
13th Dec 201910:25 amRNSBlock listing Interim Review
4th Nov 20197:00 amRNSTrading Update
16th Sep 20197:00 amRNSHalf Year Results Statement
20th Aug 201912:42 pmRNSHolding(s) in Company
16th Aug 20193:02 pmRNSDirector Shareholding
29th Jul 20197:00 amRNSDirectorate Changes
26th Jul 20197:00 amRNSAppointment of Nominated Adviser & Broker
22nd Jul 20191:34 pmRNSHolding(s) in Company
10th Jul 201912:57 pmRNSResult of Annual Meeting
14th Jun 20197:00 amRNSTrading Update
11th Jun 20197:00 amRNSBlock listing Interim Review
6th Jun 20197:00 amRNSIssue of Equity
31st May 20191:57 pmRNSAnnual Financial Report
13th May 20197:00 amRNSFinal Results for the year ending 31 December 2018
28th Mar 20197:00 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.